Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
The Jazz Pharmaceuticals plc stock is trending slightly upwards today, with an increase of €0.70 (0.690%) compared to yesterday's price.
With 23 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 184 € there is a hugely positive potential of 79.16% for Jazz Pharmaceuticals plc compared to the current price of 102.7 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.690% | -1.734% | -5.116% | -19.399% | -8.561% | -28.821% | -13.559% |
| Opko Health Inc. | -1.990% | 4.392% | -3.794% | -8.830% | -14.933% | -63.587% | -42.276% |
| Catalent Inc. | -0.170% | -0.305% | 0.019% | 20.784% | 27.087% | -41.169% | 26.473% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 0.820% | 2.500% | 17.143% | -13.380% | 2.500% | 11.818% | -41.844% |
Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat